Showing results (141-150 of 232) with videos related to
Sort By:
Pageof 24
BMC Medical Genetics|July 24, 2002
Mutational analysis of Peroxiredoxin IV: exclusion of a positional candidate for multinodular goitreEmiliano Giardina, Francesca Capon, M Rosaria D'Apice, et al.Lancet (London, England)|April 27, 2010
Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trialRichard E Pratley, Michael Nauck, Timothy Bailey, et al.Healthcare (Basel, Switzerland)|June 28, 2023
The Size of a Thyroid Nodule with ACR TI-RADS Does Not Provide a Better Prediction of the Nature of the Nodule: A Single-Center Retrospective Real-Life Observational StudyChiara Scorziello, Cosimo Durante, Marco Biffoni, et al.Updates in Surgery|August 27, 2025
Designing a SPIKES-based protocol for communicating uncertainty in indeterminate thyroid cytology: a mixed-method analysis within a pilot studyRossella Melcarne, Fabrizio Consorti, Giorgio Grani, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 27, 2010
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activityDonatella Paolino, Donato Cosco, Leda Racanicchi, et al.BMC Cancer|July 21, 2005
Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 geneIvan Presta, Franco Arturi, Elisabetta Ferretti, et al.Thyroid : Official Journal of the American Thyroid Association|June 10, 2004
Search for genetic variants in the retinoid X receptor-gamma-gene by polymerase chain reaction-single-strand conformation polymorphism in patients with resistance to thyroid hormone without mutations in thyroid hormone receptor beta geneStefano Romeo, Claudia Menzaghi, Rocco Bruno, et al.The Journal of Clinical Endocrinology and Metabolism|December 31, 2005
Clinical case seminar: in vivo and in vitro characterization of a novel germline RET mutation associated with low-penetrant nonaggressive familial medullary thyroid carcinomaLeonardo D'Aloiso, Francesca Carlomagno, Michele Bisceglia, et al.Diabetes Care|August 2, 2012
Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes: a randomized, open-label trialRichard E Pratley, Michael A Nauck, Timothy Bailey, et al.JOP : Journal of the Pancreas|September 8, 2009
Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau diseaseVito Domenico Corleto, Dario Cotesta, Luigi Petramala, et al.Pageof 24